Arteriosclerosis Thrombosis and Vascular Biology Impact Factor, Indexing, Ranking

Arteriosclerosis Thrombosis and Vascular Biology (ATVB) is a scholarly journal dedicated to publishing research in the field of Medicine. Wolters Kluwer Medknow is the publisher of this esteemed journal. The P-ISSN assigned to Arteriosclerosis Thrombosis and Vascular Biology is 1079-5642 and its abbreviated form is Arterioscler Thromb Vasc Biol.

Arteriosclerosis, Thrombosis, and Vascular Biology  (ATVB) publishes laboratory-based, translational, clinical and population research that is related to cardiovascular, peripheral vascular and cerebrovascular biology and disease. Areas of focus include atherosclerosis, lipid biology, arterial stiffening, thrombosis and hemostasis, and vascular and valvular biology. ATVB encourages submissions that use state-of-the-art approaches to illuminate mechanisms of disease and uncover new therapies and biomarkers through experimentation in animal and cellular models and in humans. The journal values novel technological developments—such as in bioengineering and with ‘omics platforms.

ATVB maintains the highest standards of methodological and statistical rigor, prioritizes engagement with the research community (readers, authors, AHA/ATVB members, and our Early Career Editorial Board mentees) and publishes original research as well as scientific statements, viewpoints, opinions and consortium papers. Through dissemination of the highest quality research, ATVB supports the overall mission of the American Heart Association: to promote longer and healthier lives.

Arteriosclerosis Thrombosis and Vascular Biology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Arteriosclerosis Thrombosis and Vascular Biology Journal is Arterioscler Thromb Vasc Biol.

The Ranking of Arteriosclerosis Thrombosis and Vascular Biology in 2023 is 715. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Arteriosclerosis Thrombosis and Vascular Biology in 2023 is 8.7. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Arteriosclerosis Thrombosis and Vascular Biology in 2023 is 2.798. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The Acceptance Rate of Arteriosclerosis Thrombosis and Vascular Biology in 2023 is 18%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.

The H-Index of Arteriosclerosis Thrombosis and Vascular Biology in 2023 is 287. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Arteriosclerosis Thrombosis and Vascular Biology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Arteriosclerosis Thrombosis and Vascular Biology is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. ProQuest
• 6. Medline
• 7. J Gate
• 8. Google Scholar
• 9. Embase
• 10. BIOSIS Previews

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Arteriosclerosis Thrombosis and Vascular Biology is Ann Marie Schmidt

Arteriosclerosis Thrombosis and Vascular Biology Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Arteriosclerosis Thrombosis and Vascular Biology is $3,806

Arteriosclerosis Thrombosis and Vascular Biology Call for paper : Arteriosclerosis Thrombosis and Vascular Biology invites original research contributions for consideration of publication in Arteriosclerosis Thrombosis and Vascular Biology journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Arteriosclerosis Thrombosis and Vascular Biology involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of Arteriosclerosis Thrombosis and Vascular Biology to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Arteriosclerosis Thrombosis and Vascular Biology guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago